(Q35546265)

8 August 2017

title

Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis (English)

1 reference

8 August 2017

Reiki Nishimura

1

1 reference

8 August 2017

Tomofumi Osako

2

1 reference

8 August 2017

Yasuhiro Okumura

3

1 reference

8 August 2017

Rumiko Tashima

4

1 reference

8 August 2017

Yasuo Toyozumi

5

1 reference

8 August 2017

Nobuyuki Arima

6

1 reference

8 August 2017

publication date

17 October 2011

1 reference

World Journal of Surgical Oncology

8 August 2017

published in

1 reference

8 August 2017

volume

9

1 reference

8 August 2017

page(s)

131

1 reference

Creative Commons Attribution 2.0 Generic

8 August 2017

copyright license

start time

17 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1477-7819-9-131

0 references

cites work

Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Breast cancer subtypes and outcome after local and regional relapse.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Should liver metastases of breast cancer be biopsied to improve treatment choice?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214885

Treatment of breast cancer

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22004841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22004841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22004841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1477-7819-9-131

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference

8 August 2017

1 reference